• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过RANKL与干扰素-γ之间的信号串扰实现T细胞介导的破骨细胞生成调节。

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.

作者信息

Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T

机构信息

Department of Immunology, Faculty of Medicine and Graduate School of Medicine, University of Tokyo, Japan.

出版信息

Nature. 2000 Nov 30;408(6812):600-5. doi: 10.1038/35046102.

DOI:10.1038/35046102
PMID:11117749
Abstract

Bone resorption is regulated by the immune system, where T-cell expression of RANKL (receptor activator of nuclear factor (NF)-kappaB ligand), a member of the tumour-necrosis factor family that is essential for osteoclastogenesis, may contribute to pathological conditions, such as autoimmune arthritis. However, whether activated T cells maintain bone homeostasis by counterbalancing the action of RANKL remains unknown. Here we show that T-cell production of interferon (IFN)-gamma strongly suppresses osteoclastogenesis by interfering with the RANKL-RANK signalling pathway. IFN-gamma induces rapid degradation of the RANK adapter protein, TRAF6 (tumour necrosis factor receptor-associated factor 6), which results in strong inhibition of the RANKL-induced activation of the transcription factor NF-kappaB and JNK. This inhibition of osteoclastogenesis is rescued by overexpressing TRAF6 in precursor cells, which indicates that TRAF6 is the target critical for the IFN-gamma action. Furthermore, we provide evidence that the accelerated degradation of TRAF6 requires both its ubiquitination, which is initiated by RANKL, and IFN-gamma-induced activation of the ubiquitin-proteasome system. Our study shows that there is cross-talk between the tumour necrosis factor and IFN families of cytokines, through which IFN-gamma provides a negative link between T-cell activation and bone resorption. Our results may offer a therapeutic approach to treat the inflammation-induced tissue breakdown.

摘要

骨吸收受免疫系统调节,其中肿瘤坏死因子家族成员核因子κB受体激活配体(RANKL)的T细胞表达对破骨细胞生成至关重要,可能导致自身免疫性关节炎等病理状况。然而,活化的T细胞是否通过平衡RANKL的作用来维持骨稳态仍不清楚。在此我们表明,T细胞产生的干扰素γ(IFN-γ)通过干扰RANKL-RANK信号通路强烈抑制破骨细胞生成。IFN-γ诱导RANK衔接蛋白肿瘤坏死因子受体相关因子6(TRAF6)快速降解,导致RANKL诱导的转录因子核因子κB和JNK活化受到强烈抑制。在前体细胞中过表达TRAF6可挽救这种对破骨细胞生成的抑制,这表明TRAF6是IFN-γ作用的关键靶点。此外,我们提供证据表明,TRAF6的加速降解既需要RANKL引发的其泛素化,也需要IFN-γ诱导的泛素-蛋白酶体系统活化。我们的研究表明,肿瘤坏死因子和细胞因子IFN家族之间存在相互作用,通过这种相互作用,IFN-γ在T细胞活化和骨吸收之间提供了一个负向联系。我们的结果可能为治疗炎症诱导的组织破坏提供一种治疗方法。

相似文献

1
T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.通过RANKL与干扰素-γ之间的信号串扰实现T细胞介导的破骨细胞生成调节。
Nature. 2000 Nov 30;408(6812):600-5. doi: 10.1038/35046102.
2
12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.12-O-十四酰佛波醇-13-乙酸酯(TPA)通过抑制RANKL诱导的NF-κB活化来抑制破骨细胞生成。
J Bone Miner Res. 2003 Dec;18(12):2159-68. doi: 10.1359/jbmr.2003.18.12.2159.
3
TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.TRAF2对于肿瘤坏死因子-α诱导的破骨细胞生成至关重要。
J Bone Miner Res. 2005 May;20(5):840-7. doi: 10.1359/JBMR.041225. Epub 2004 Dec 20.
4
RANKing intracellular signaling in osteoclasts.破骨细胞内信号通路的排名
IUBMB Life. 2005 Jun;57(6):389-95. doi: 10.1080/15216540500137669.
5
IFN-gamma-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL.产生干扰素-γ的人T细胞通过RANKL的表达直接诱导人单核细胞形成破骨细胞。
Eur J Immunol. 2005 Nov;35(11):3353-63. doi: 10.1002/eji.200526141.
6
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.活化的T细胞通过骨保护素配体调节佐剂性关节炎中的骨质流失和关节破坏。
Nature. 1999 Nov 18;402(6759):304-9. doi: 10.1038/46303.
7
Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.新型NF-κB抑制剂(-)-DHMEQ通过下调NFATc1抑制RANKL诱导的破骨细胞生成。
J Bone Miner Res. 2005 Apr;20(4):653-62. doi: 10.1359/JBMR.041213. Epub 2004 Dec 6.
8
Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.白细胞介素(IL)-18通过类风湿关节炎中的滑膜T细胞刺激破骨细胞形成:与IL-1β和肿瘤坏死因子α的比较
Ann Rheum Dis. 2004 Nov;63(11):1379-86. doi: 10.1136/ard.2003.018481.
9
Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.没食子儿茶素-3-没食子酸酯通过下调 c-Fos 表达和抑制核因子-κB 信号抑制破骨细胞生成。
Mol Pharmacol. 2010 Jan;77(1):17-25. doi: 10.1124/mol.109.057877. Epub 2009 Oct 14.
10
[Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro].[体外实验中,抗坏血酸抑制受体激活核因子κB配体诱导的RAW264.7细胞来源破骨细胞的形成及功能]
Zhonghua Yi Xue Za Zhi. 2004 Dec 17;84(24):2102-6.

引用本文的文献

1
The mechanism of NK cell expression of RANKL/RANK/OPG pathway in mouse models of femoral head necrosis.小鼠股骨头坏死模型中自然杀伤细胞RANKL/RANK/OPG途径的表达机制
Ann Med Surg (Lond). 2025 Jul 18;87(9):5494-5502. doi: 10.1097/MS9.0000000000003615. eCollection 2025 Sep.
2
Unleashing NK cells for cancer immunotherapy in lung cancer: biologic challenges and clinical advances.释放自然杀伤细胞用于肺癌的癌症免疫治疗:生物学挑战与临床进展
J Exp Clin Cancer Res. 2025 Aug 23;44(1):251. doi: 10.1186/s13046-025-03503-7.
3
Are Dietary Habits the Missing Link Between Hashimoto's Thyroiditis and Osteoporosis?
饮食习惯是桥本甲状腺炎与骨质疏松症之间缺失的环节吗?
Nutrients. 2025 Jun 25;17(13):2109. doi: 10.3390/nu17132109.
4
IFNγ production during cell interactions distinguishes localized from diffuse pigmented villonodular synovitis and rheumatoid arthritis.细胞相互作用期间的γ干扰素产生可区分局限性与弥漫性色素沉着绒毛结节性滑膜炎以及类风湿性关节炎。
Arthritis Res Ther. 2025 Jul 4;27(1):134. doi: 10.1186/s13075-025-03590-z.
5
Osteoimmunology: Crosstalk Between T Cells and Osteoclasts in Osteoporosis.骨免疫学:骨质疏松症中T细胞与破骨细胞之间的相互作用
Clin Rev Allergy Immunol. 2025 Apr 10;68(1):41. doi: 10.1007/s12016-025-09046-1.
6
Osteoimmunology in Osteoarthritis: Unraveling the Interplay of Immunity, Inflammation, and Joint Degeneration.骨关节炎中的骨免疫学:揭示免疫、炎症与关节退变之间的相互作用
J Inflamm Res. 2025 Mar 19;18:4121-4142. doi: 10.2147/JIR.S514002. eCollection 2025.
7
T cell related osteoimmunology in fracture healing: Potential targets for augmenting bone regeneration.骨折愈合中与T细胞相关的骨免疫学:促进骨再生的潜在靶点。
J Orthop Translat. 2025 Feb 4;51:82-93. doi: 10.1016/j.jot.2024.12.004. eCollection 2025 Mar.
8
Unveiling sex-disparities and the impact of gender-affirming hormone therapy on periodontal health.揭示性别差异以及性别确认激素疗法对牙周健康的影响。
Front Dent Med. 2024 Sep 16;5:1430193. doi: 10.3389/fdmed.2024.1430193. eCollection 2024.
9
The impact of the soluble epoxide hydrolase cascade on periodontal tissues.可溶性环氧化物水解酶级联反应对牙周组织的影响。
Front Dent Med. 2023 Feb 1;4:1129371. doi: 10.3389/fdmed.2023.1129371. eCollection 2023.
10
Monocyte STAT1 phosphorylation and treatment response of JAK inhibitors in chronic nonbacterial osteomyelitis.慢性非细菌性骨髓炎中单核细胞STAT1磷酸化与JAK抑制剂的治疗反应
Pediatr Rheumatol Online J. 2025 Jan 23;23(1):6. doi: 10.1186/s12969-025-01059-6.